Products for Research Use Only
RegisterLogin

Sacituzumab (powder)

CAT: 0804-HY-P99045ASize: 1 EachDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99045ASize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Sacituzumab (powder) is a humanized IgG1 monoclonal antibody targeting Trophoblast cell surface antigen 2 (TROP2). Sacituzumab (powder) demonstrates a lack of antitumor effects alone and does not inhibit the function of TROP-2 during tumor metastasis, binding to the linear epitopes of TROP-2 protein. Sacituzumab (powder) can be used for the synthesis of antibody-drug conjugates (ADC) drug Sacituzumab govitecan. Sacituzumab govitecan can be used in the field of triple-negative breast cancer[1][2][3][4].
CAS Number
1796566-95-4
UNSPSC
12352203
Target
ADC Antibody; TROP2
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Field of Research
Cancer
Purity
98.33
Smiles
[Sacituzumab(powder)]
Molecular Weight
(145.52 kDa)
References & Citations
[1]Zhou DD, et al. Elucidating the development, characterization, and antitumor potential of a novel humanized antibody against Trop2[J]. Int J Biol Macromol. 2023 Dec 31;253 (Pt 6) :127105.|[2]Sun M, et al. Structural insights into the cis and trans assembly of human trophoblast cell surface antigen 2[J]. iScience. 2021 Sep 30;24 (10) :103190. |[3]Shih LB, et al. In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer[J]. Cancer Res. 1995 Dec 1;55 (23 Suppl) :5857s-5863s. |[4]Bardia A, et al. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer. Ann Oncol. 2021 Sep;32 (9) :1148-1156.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P99045-01Sacituzumab
HY-164789-01Sacituzumab tirumotecan
HY-132254-01Sacituzumab govitecan
HY-132254A-01Sacituzumab govitecan (solution)
HY-P99155AZalutumumab (powder)
HY-P99041BPanitumumab (powder)
HY-P99854ADisitamab (powder)
HY-N13208Stevia Powder
HY-P99225AMirvetuximab (powder)
HY-P99271ATisotumab (powder)

Alternative Products

CatalogName
T35397-01Sacituzumab
CLA1052Sacituzumab govitecan
GTR18291820-01Sacituzumab Antibody
GTR18874300-01Sacituzumab Govitecan (Sacituzumab Govitecan) ELISA KIT
T9901A-217-01Sacituzumab MMAE
T9901A-237-01Sacituzumab tirumotecan
JL58341-01Human Sacituzumab Govitecan (Sacituzumab Govitecan) ELISA Kit
DY373018Sacituzumab ELISA Kit
MBS1563473-01Research Grade Sacituzumab
MBS1581014-01Sacituzumab govitecan (ADC)

Popular Products